InvestorsHub Logo
Replies to #84586 on Biotech Values
icon url

righty

10/06/09 8:18 AM

#84588 RE: DewDiligence #84586

Why did you edit out the information about the ITT population?

yknow...the part that followed

"the Intent-to-Treat (ITT) population of the primary efficacy endpoint"

Why would you edit that out?

that in and of itself is somewhat suspicious

here is what the real pr said

"Analysis of the Intent-to-Treat (ITT) population of the primary efficacy endpoint (which includes all study patients even if they failed to comply with the protocol and study requirements) favored Ketotransdel® compared to placebo but not to a degree that reached statistical significance. "
(you then edited out portions of the following important official news release content and submitted your own bla bla bla comments????????? BY WHAT AUTHORITY????

"and We believe that this finding was not due to a lack of effect of Ketotransdel®, but rather due to patient compliance issues, non-adherence to protocol procedures and other potentially confounding factors (e.g., incorrect use of study drugs and/or concomitant use of unallowed drugs).
"


why on eartht would you do that?

are you aware of what ITT population consists of?

are you even clued in to the INSIGNIFICANCE OF THIS DATA????

FRIGGEN AMAZING MANIPULATION OF THE DATA